Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 36507690

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Dec 15
First author
Dickinson MJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Dec 15;387(24):2285-2286. doi: 10.1056/NEJMe2212732.
    note
    Source null
    related pmid
    36507659
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Dec 15;387(24):2287-2290. doi: 10.1056/NEJMe2208708.
    note
    Source null
    related pmid
    36507665
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2023 Feb;20(2):64. doi: 10.1038/s41571-022-00725-y.
    note
    Source null
    related pmid
    36600006
    relationship
    Comment in

Authors and identifiers

  1. name
    Dickinson MJ
    type
    Author
  2. name
    Carlo-Stella C
    type
    Author
  3. name
    Morschhauser F
    type
    Author
  4. name
    Bachy E
    type
    Author
  5. name
    Corradini P
    type
    Author
  6. name
    Iacoboni G
    type
    Author
  7. name
    Khan C
    type
    Author
  8. name
    Wróbel T
    type
    Author
  9. name
    Offner F
    type
    Author
  10. name
    Trněný M
    type
    Author
  11. name
    Wu SJ
    type
    Author
  12. name
    Cartron G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dickinson MJ
    type
    Author
  2. name
    Carlo-Stella C
    type
    Author
  3. name
    Morschhauser F
    type
    Author
  4. name
    Bachy E
    type
    Author
  5. name
    Corradini P
    type
    Author
  6. name
    Iacoboni G
    type
    Author
  7. name
    Khan C
    type
    Author
  8. name
    Wróbel T
    type
    Author
  9. name
    Offner F
    type
    Author
  10. name
    Trněný M
    type
    Author
  11. name
    Wu SJ
    type
    Author
  12. name
    Cartron G
    type
    Author
bibliography ids
  1. nci-bib-e187c782e7cad9eb3e1f3f1c
book metadata
content sha256
844ca894a4b9dbb1e3750e2d81831affc5cb0a6496e0b57f733e586db26dd30c
document type
citation
dois
  1. 10.1056/NEJMoa2206913
electronic publication date
display
2022 Dec 11
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36507690
immutable id
pubmed:36507690@844ca894a4b9dbb1e3750e2d81831affc5cb0a6496e0b57f733e586db26dd30c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
24
name
The New England journal of medicine
nlm unique id
0255562
pages
2220-2231
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Dec 15;387(24):2285-2286. doi: 10.1056/NEJMe2212732.
    note
    Source null
    related pmid
    36507659
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Dec 15;387(24):2287-2290. doi: 10.1056/NEJMe2208708.
    note
    Source null
    related pmid
    36507665
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2023 Feb;20(2):64. doi: 10.1038/s41571-022-00725-y.
    note
    Source null
    related pmid
    36600006
    relationship
    Comment in
outcomes validated
false
pmid
36507690
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
e0e6759c9dd0793af737d48b267d28f9aa04fdc9a01a0452f7531fbbf21c6fed
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2022 Dec 15
precision
day
year
2022
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36507690/
title
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice